Sanofi
Why Robinhood?
You can watch Sanofi and buy or sell other stocks, options, and ETFs commission-free!About SNY
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines.
SNY Key Statistics
SNY News
The European Medicines Agency's Committee for Medicinal Products for Human Use has issued positive opinions for treatments from Bristol-Myers Squibb (NYSE:BMY),...
Sanofi India Limited ( ) has announced that it will pay a dividend of ₹117.00 per share on the 13th of June. The dividend yield of 2.0% is still a nice boost to...
It has been a busy week for pharma giants reporting their latest quarterly earnings and a lot of them have exceeded analysts’ estimates. HGTV's Property Brot...
Analyst ratings
79%
of 24 ratingsMore SNY News
Sanofi SA (SNY) has released an update. Sanofi SA reports a robust first quarter with a 7% sales growth, underpinned by successful product launches and a stron...
Loading... Loading... Thursday, Sanofi SA SNY reported first-quarter operating income of 2.8 billion euros, down 14.7% Y/Y and 4.2% on constant currency. The...
In this article: AstraZeneca soundly topped analyst views while Sanofi narrowed its losses. Both stocks surged in early trade....
Sanofi (NASDAQ:SNY) shares jumped by over 5% in the early trading session today after the French healthcare major delivered a healthy performance for the first...
Sanofi expects 2024 business EPS to remain roughly stable excluding the impact of an expected effective tax rate increase to 21% and decrease low single-digit a...
(Adds strategy background in paragraph 7, Beyfortus sales in last paragraph) By Ludwig Burger April 25 (Reuters) - Sanofi's first-quarter operating income fel...
Sanofi - Aventis Groupe Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance Paris, April 25, 2024 Sales growth of 6.7% at CER...